Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
Go back to Ligand Reports Fourth Quarter and Full Year 2023 Financial Results| ALDEYRA THERAPEUT (NASDAQ: ALDX) | Delayed: 1.48 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.48 | 52 Week High | $8.19 | |||
| Open | $1.47 | 52 Week Low | $3.39 | |||
| Day High | $1.49 | P/E | N/A | |||
| Day Low | $1.46 | EPS | $0.00 | |||
| Volume | 486,185 | |||||
| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 285.60 -4.14 (1.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $289.74 | 52 Week High | $139.79 | |||
| Open | $287.41 | 52 Week Low | $82.07 | |||
| Day High | $290.00 | P/E | 664.19 | |||
| Day Low | $285.47 | EPS | $0.43 | |||
| Volume | 132,390 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 150.33 -2.01 (1.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $152.34 | 52 Week High | $65.46 | |||
| Open | $150.83 | 52 Week Low | $47.97 | |||
| Day High | $152.22 | P/E | 102.27 | |||
| Day Low | $150.09 | EPS | $1.47 | |||
| Volume | 4,397,470 | |||||
| (NASDAQ: TVTX) | Delayed: 65.28 -1.26 (1.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.54 | 52 Week High | $ | |||
| Open | $66.04 | 52 Week Low | $ | |||
| Day High | $67.11 | P/E | N/A | |||
| Day Low | $65.04 | EPS | $ | |||
| Volume | 1,050,706 | |||||
| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 34.87 +0.89 (2.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $33.98 | 52 Week High | $5.17 | |||
| Open | $33.75 | 52 Week Low | $0.94 | |||
| Day High | $34.95 | P/E | N/A | |||
| Day Low | $33.56 | EPS | $0.00 | |||
| Volume | 1,402,465 | |||||
| (NASDAQ: VRNA) | Delayed: 106.91 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $106.91 | 52 Week High | $ | |||
| Open | $106.91 | 52 Week Low | $ | |||
| Day High | $106.91 | P/E | N/A | |||
| Day Low | $106.91 | EPS | $ | |||
| Volume | 17,860 | |||||

